Skip to main content
. 2015 Nov 13;48(6):705–717. doi: 10.1111/cpr.12224

Figure 5.

Figure 5

Biological evaluation in MePR2B cells for compounds 4 and 5. Cell cycle analysis (a) and pre‐G1 phase (b) in MePR2B cells untreated (DMSO, negative control), treated with SAHA (positive control) at 5 μm and with compounds 4 and 5 at 10 and 15 μm for the indicated time. All data are expressed as means ± standard deviation (SD) of three independent experiments. Statistical significance P‐value: 0.001 except * and # marked as 0.05.